These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 38507997)
21. Design, Synthesis, and Biological Evaluation of Novel Thiazolyl Substituted Bis-pyrazole Oxime Derivatives with Potent Antitumor Activities by Selectively Inducing Apoptosis and ROS in Cancer Cells. Xiong B; Chen S; Zhu P; Huang M; Gao W; Zhu R; Qian J; Peng Y; Zhang Y; Dai H; Ling Y Med Chem; 2019; 15(7):743-754. PubMed ID: 30147012 [TBL] [Abstract][Full Text] [Related]
22. Cationic lipid-conjugated dexamethasone as a selective antitumor agent. Sau S; Banerjee R Eur J Med Chem; 2014 Aug; 83():433-47. PubMed ID: 24992071 [TBL] [Abstract][Full Text] [Related]
23. Natural Hypoxia is Not a Limiting Factor in Evaluating the Novel Arylidene Derivative MLT-401 Against an In Vitro Colorectal Cancer Model. Bin-Jaliah I Cell Physiol Biochem; 2018; 46(5):2082-2089. PubMed ID: 29723868 [TBL] [Abstract][Full Text] [Related]
24. Potency and Selectivity Optimization of Tryptophanol-Derived Oxazoloisoindolinones: Novel p53 Activators in Human Colorectal Cancer. Barcherini V; Almeida J; Lopes EA; Wang M; Magalhães E Silva D; Mori M; Wang S; Saraiva L; Santos MMM ChemMedChem; 2021 Jan; 16(1):250-258. PubMed ID: 32737944 [TBL] [Abstract][Full Text] [Related]
25. Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression. Raha P; Thomas S; Thurn KT; Park J; Munster PN Breast Cancer Res; 2015 Feb; 17(1):26. PubMed ID: 25848915 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of p53-Murine Double Minute 2 (MDM2) Interactions with 3,3'-Spirocyclopentene Oxindole Derivatives. Gicquel M; Gomez C; Garcia Alvarez MC; Pamlard O; Guérineau V; Jacquet E; Bignon J; Voituriez A; Marinetti A J Med Chem; 2018 Oct; 61(20):9386-9392. PubMed ID: 30221935 [TBL] [Abstract][Full Text] [Related]
27. Antineoplastic effects of α-santalol on estrogen receptor-positive and estrogen receptor-negative breast cancer cells through cell cycle arrest at G2/M phase and induction of apoptosis. Santha S; Bommareddy A; Rule B; Guillermo R; Kaushik RS; Young A; Dwivedi C PLoS One; 2013; 8(2):e56982. PubMed ID: 23451128 [TBL] [Abstract][Full Text] [Related]
28. Estradiol agonists inhibit human LoVo colorectal-cancer cell proliferation and migration through p53. Hsu HH; Kuo WW; Ju DT; Yeh YL; Tu CC; Tsai YL; Shen CY; Chang SH; Chung LC; Huang CY World J Gastroenterol; 2014 Nov; 20(44):16665-73. PubMed ID: 25469035 [TBL] [Abstract][Full Text] [Related]
35. Design, Synthesis and Antitumor Activity of Novel Dispiro[oxindole-cyclohexanone]- pyrrolidines. Gouda M; Bawazeer M; Hegazy L; Azab M; Elagawany M; Rateb M; Yaseen M; Elgendy B Curr Pharm Des; 2022; 28(3):198-207. PubMed ID: 34176458 [TBL] [Abstract][Full Text] [Related]
36. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft. Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847 [TBL] [Abstract][Full Text] [Related]
37. Synthesis of substituted biphenyl methylene indolinones as apoptosis inducers and tubulin polymerization inhibitors. Donthiboina K; Anchi P; Sri Ramya PV; Karri S; Srinivasulu G; Godugu C; Shankaraiah N; Kamal A Bioorg Chem; 2019 May; 86():210-223. PubMed ID: 30716619 [TBL] [Abstract][Full Text] [Related]
38. Design and Synthesis of DNA-Interactive β-Carboline-Oxindole Hybrids as Cytotoxic and Apoptosis-Inducing Agents. Tokala R; Thatikonda S; Vanteddu US; Sana S; Godugu C; Shankaraiah N ChemMedChem; 2018 Sep; 13(18):1909-1922. PubMed ID: 30010248 [TBL] [Abstract][Full Text] [Related]
39. Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo. Chattopadhyay M; Kodela R; Nath N; Barsegian A; Boring D; Kashfi K Biochem Pharmacol; 2012 Mar; 83(6):723-32. PubMed ID: 22209867 [TBL] [Abstract][Full Text] [Related]